For the second time this year, German drugmaker Bayer has nabbed an oncology leader from GlaxoSmithKline, appointing Tara Frenkl, M.D., to lead oncology development for its oncology strategic business unit.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,